Rocket Lab (RKLB) price prediction: will it hit $293 or $76?

Every Rocket Lab (RKLB) price prediction hinges on the same event: the first launch of the Neutron rocket, penciled in for the fourth quarter of 2026. That framing is wrong. The man building the rocket says so himself. “Neutron is certainly mission enabling, but it’s not mission critical,” chief executive Peter Beck told investors this year. The company that the market prices as a binary bet on one launch date is, on the numbers, a vertically integrated space-infrastructure business that happens to also launch rockets. RKLB trades near $101.65 after a record first quarter, and Wall Street targets now span an extraordinary range — from a $76 bear case to Morgan Stanley’s $293 bull case. That 285% gap is not really an argument about Neutron. It is an argument about what kind of company you think you are buying.

Here is the insight the Neutron obsession buries. In the first quarter of 2026, Rocket Lab’s Space Systems segment generated $136.7 million of the company’s $200.35 million in revenue — roughly 68% of the top line — while the launch business contributed just $63.7 million. The rocket, in other words, is the smaller half. The compounding engine is satellites, spacecraft components, and the $8 billion Iridium acquisition that turns Rocket Lab into an end-to-end space company. It is the Amazon pattern: the market fixated on the bookstore while AWS quietly became the business. Judge RKLB as a launch stock and the $76 bear case looks reasonable on a slipped rocket. Judge it as a space-systems compounder with a $2.2 billion backlog, and the bull case writes itself.

Key Rocket Lab (RKLB) facts and figures

• Q1 2026 revenue: a record $200.35 million, with net loss narrowing to $45.02 million — Rocket Lab, May 2026
• Segment split: Space Systems $136.7M (68%) vs Launch $63.7M — CNBC
• Contracted backlog: more than $2.20 billion, a sharp year-on-year rise — Rocket Lab Q1 2026
• Launch manifest: 70+ contracted missions; more launches sold in Q1 2026 than in all of 2025 — CNBC
• Neutron debut: targeted for Q4 2026, “on track” per management — Spaceflight Now
• Analyst targets: Morgan Stanley bull case $293; Street high $150, low $76, consensus Buy across 17 analysts — public.com
• All-time high: $151.00 on 27 May 2026, before volatility around the $8 billion Iridium deal — StockAnalysis

What Rocket Lab actually is, and why the stock is so volatile

Rocket Lab is best understood as two businesses stapled together. The first, and the one that made its name, is Launch: the small Electron rocket, with more than 50 successful flights, and the larger, reusable Neutron now in development. The second, and the larger by revenue, is Space Systems: satellites, spacecraft, solar panels, flight software, and components that Rocket Lab sells to other operators and increasingly uses to build and fly its own constellations. The $8 billion agreement to acquire satellite operator Iridium pushes the company further down the “own the whole stack” path — from launching other people’s payloads to owning the payloads, the satellites, and the recurring service revenue underneath them.

Think of it as the difference between a trucking company and a logistics empire. Anyone can run a truck; the durable margins sit in owning the network, the depots, and the contracts. Rocket Lab’s launch business is the truck — visible, dramatic, and cyclical. Space Systems and the Iridium deal are the network. That is why the record Q1 mattered more for the backlog line than the revenue line: contracted backlog above $2.2 billion is forward revenue the market can underwrite, and it grew because Rocket Lab closed what it called the largest launch contract in its history, a bulk purchase of Neutron and Electron flights from an undisclosed customer. Retail traders have noticed the shift too, which is why brokers are broadening access, as we covered when Fortrade added AI, space, and networking stocks to meet demand moving beyond the mega-caps.

Beck was characteristically blunt about where the constraint is not: “Demand is just not one of [the things I worry about],” he said on the earnings call. “The backlog is super healthy for a number of years.”

The bull case: a $293 target built on backlog, not hope

The bullish argument for RKLB is not a moon-shot on Neutron; it is a compounding-backlog story with a launch-cadence kicker. Start with the demand signal. Selling more launches in a single quarter than in an entire prior year, and lifting backlog past $2.2 billion, tells you the order book is filling faster than the company can fly. Add the Space Systems mix — roughly two-thirds of revenue from higher-visibility, less binary work — and you have a business whose valuation does not live or die on one launch window.

Layer Neutron on top as optionality. Neutron is a reusable medium-lift rocket aimed squarely at the market SpaceX’s Falcon 9 dominates. If it flies and proves reusable, Rocket Lab graduates from the small-satellite niche into the constellation-deployment big leagues — the highest-volume, highest-value segment of the launch market. That is the leg that justifies Morgan Stanley’s $293 bull case: not the base outcome, but the scenario where Neutron converts backlog into a recurring, high-margin cadence. The same “picks-and-shovels plus optionality” logic underpins the AI-infrastructure names we mapped in our Nebius (NBIS) price prediction, where the market pays up for owning the rails of a structural buildout.

There is also a defense pillar the momentum crowd underweights. Rocket Lab flagged growing national-security and defense demand alongside the commercial backlog in Q1, with Beck describing overall demand as “super healthy” as defense and Neutron orders build, per Yahoo Finance. Government work tends to be stickier and higher-margin than commercial launch, and it leans on Rocket Lab’s proven Electron vehicle — now past 50 successful flights — rather than on the unproven Neutron. That diversification is precisely what a launch-only framing of the stock misses: the backlog is not one bet, it is several.

Beck framed the reusability challenge — the crux of the bull case — with an engineer’s candor: “If we just had to go up, it’s super easy, we’d be in orbit by now. But the reality is, it’s just as important to go up as it is to come back down and be reusable again.” Reusability is what turns a rocket from a cost center into a margin machine, and it is the single technical hurdle that gates the upside. Investors comfortable with that framing tend to view RKLB the way they view other high-beta buildout stories, such as the one in our Nvidia price prediction.

The market data: mapping $293 against $76

Stitch the numbers together and a cleaner picture emerges than either camp offers alone. With RKLB near $101.65, the consensus 12-month target sits around $108-$113 — implying the average analyst sees only modest upside from here, having already ridden the stock to a $151 all-time high in May 2026. The action is in the tails. The $293 bull case and the $76 bear case are not two estimates of the same variable; they are two different companies.

The synthesis neither side states: RKLB’s near-term price is anchored by Space Systems and backlog, while its tail outcomes are set by Neutron. That means the stock can hold the low $100s on fundamentals even if Neutron slips — and only re-rates toward $293 once reusability is proven. The bear’s $76 requires both a Neutron delay and a wobble in the core business at the same time.

The bear case and the risks the momentum crowd ignores

The case for $76 is not frivolous. Start with profitability: Rocket Lab is still loss-making, posting a $45.02 million net loss in Q1 2026 even at record revenue. A company burning cash while pouring capital into Neutron development and a $8 billion acquisition is, by definition, dependent on capital markets staying friendly. Any tightening of financing conditions raises the cost of that ambition.

Then there is the Neutron timeline itself. Beck says Q4 2026 is “on track,” but that hinges on the Archimedes engine surviving what he described as a battery of “nasty” qualification tests, per Stocktwits. Rocket development slips; it is the base rate of the industry, not the exception. A push into 2027 would not break the thesis, but it would deflate the momentum premium that carried RKLB to $151. Add the volatility already seen around the Iridium announcement, the integration risk of absorbing a satellite operator, and rising competition — SpaceX’s Falcon 9 incumbency, plus a field of new launch entrants — and the bear’s downside math is coherent. The stock is priced for execution; any stumble compresses the multiple fast.

Crucially, Beck’s own framing is a double-edged sword. Telling investors Neutron is “not mission critical” and that the real value drivers are “needle moving for the company in the next 12 to 24 months” reassures long-term holders — but it also concedes that the catalyst the momentum crowd is trading is not, by the CEO’s own account, the thing that matters most. That gap between the narrative price and the operational reality is exactly where sharp corrections live. For context on how quickly sentiment-driven names can reprice, see our Meta price prediction.

What happens next: three scenarios for RKLB

First, the near-term floor is Space Systems, not the rocket. Expect RKLB to trade on backlog conversion and Space Systems execution through the next couple of quarters. As long as backlog keeps climbing and the segment delivers, the stock has fundamental support in the roughly $95-$120 band even without Neutron news. Watch the backlog line on every print — it is the leading indicator that matters.

Second, Neutron is the re-rating switch, and it is binary. A successful, on-time Q4 2026 debut — especially a clean demonstration of reusability — is the event that opens the path toward the triple-digit bull targets, because it converts Rocket Lab from a small-launch specialist into a Falcon 9 challenger. A slip into 2027 does the opposite: it does not break the company, but it drains the premium and likely marks time in the low $100s or below.

Third, the twelve-month base case clusters near the $108-$113 consensus, with the tails doing the real work. Reaching Morgan Stanley’s $293 requires Neutron to fly and reusability to prove out on schedule; falling to $76 requires a Neutron delay stacked on a core-business wobble. Between those poles, RKLB remains what it has quietly become — a space-infrastructure compounder wearing a rocket company’s volatility. Investors should size it as the high-beta position it is, watch the backlog more closely than the launch calendar, and remember that this is analysis, not investment advice.

Frequently asked questions

What is the Rocket Lab (RKLB) price target for 2026?

Analyst 12-month targets on Rocket Lab cluster around a consensus of $108-$113, with a Street high near $150 and a low of $76, according to public.com and MarketBeat tallies. Morgan Stanley has set a bull-case scenario target of $293. The consensus rating across 17 analysts is Buy, with 53% rating the stock a Strong Buy.

Can Rocket Lab stock reach $293?

Morgan Stanley’s $293 is a bull-case scenario, not a base target. Reaching it would likely require Rocket Lab’s Neutron rocket to launch on schedule in Q4 2026 and prove reusable, converting the $2.2 billion backlog into a recurring, high-margin launch cadence that challenges SpaceX’s Falcon 9. Without a successful Neutron, the stock is more likely to trade near the $108-$113 consensus.

Why is Rocket Lab stock so volatile?

RKLB behaves like a high-beta bet on a single catalyst — the Neutron debut — layered on a still-loss-making balance sheet. It hit an all-time high of $151 in May 2026 before selling off around the $8 billion Iridium acquisition. Because the price embeds execution expectations, any news on Neutron timing, engine testing, or the acquisition moves the stock sharply.

Is Rocket Lab profitable?

Not yet. Rocket Lab reported a net loss of $45.02 million in Q1 2026, even as revenue hit a record $200.35 million. The company is investing heavily in Neutron development and the Iridium acquisition. Management points to expanding backlog and Space Systems growth as the path to profitability, but free cash flow remains negative during the buildout.

When will Rocket Lab’s Neutron rocket launch?

Rocket Lab is targeting a first Neutron launch in the fourth quarter of 2026, which management describes as “on track.” The timeline depends on the Archimedes engine passing a demanding series of qualification tests. A slip into 2027 is a realistic risk given the industry’s base rate for rocket-development delays, and would likely pressure the stock’s momentum premium.

What is more important for Rocket Lab: Neutron or Space Systems?

By revenue, Space Systems is larger — $136.7 million versus $63.7 million for Launch in Q1 2026 — and CEO Peter Beck has called Neutron “mission enabling, but not mission critical.” Space Systems and the Iridium deal drive near-term fundamentals, while Neutron represents the upside optionality that could re-rate the stock toward bull-case targets.